Juliann M Di Fiore1, Richard J Martin2, Hong Li3, Nathan Morris3, Waldemar A Carlo4, Neil Finer5, Michele Walsh2. 1. Division of Neonatology, Rainbow Babies & Children's Hospital, Department of Pediatrics, Case Western Reserve University, Cleveland, OH. Electronic address: jmd3@case.edu. 2. Division of Neonatology, Rainbow Babies & Children's Hospital, Department of Pediatrics, Case Western Reserve University, Cleveland, OH. 3. Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, OH. 4. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL. 5. Department of Pediatrics, University of California, San Diego, CA.
Abstract
OBJECTIVE: To characterize actual achieved patterns of oxygenation in infants born appropriate vs small for gestational age (SGA) randomized to a lower (85-89%) vs higher (91%-95%) oxygen saturation target in the Surfactant Positive Pressure and Oxygen Trial. To determine the association between achieved oxygen saturation levels and survival in infants born appropriate vs SGA enrolled in the Surfactant Positive Pressure and Oxygen Trial. STUDY DESIGN:Median oxygen saturation and intermittent hypoxemia events (<80%, 20 seconds-5 minutes) were documented in 1054 infants of 240/7-276/7 weeks of gestation while receiving supplemental oxygen during the first 3 days of life. RESULTS: Lower target infants who were small for gestational age had the lowest oxygen saturation and highest incidence of intermittent hypoxemia during the first 3 days of life. The lowest quartile of oxygen saturation (≤92%) during the first 3 days of life was associated with lower 90-day survival for both infants born appropriate and SGA. An increased incidence of intermittent hypoxemia events during the first 3 days of life was associated with lower 90-day survival only in infants born SGA. CONCLUSION: Lower achieved oxygen saturation during the first 3 days of life was associated with lower 90-day survival in extremely preterm infants. Infants born SGA had enhanced vulnerability to lower oxygen saturation targets as evidenced by lower achieved oxygen saturation and an association between increased intermittent hypoxemia events and lower survival. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00233324.
RCT Entities:
OBJECTIVE: To characterize actual achieved patterns of oxygenation in infants born appropriate vs small for gestational age (SGA) randomized to a lower (85-89%) vs higher (91%-95%) oxygen saturation target in the Surfactant Positive Pressure and Oxygen Trial. To determine the association between achieved oxygen saturation levels and survival in infants born appropriate vs SGA enrolled in the Surfactant Positive Pressure and Oxygen Trial. STUDY DESIGN: Median oxygen saturation and intermittent hypoxemia events (<80%, 20 seconds-5 minutes) were documented in 1054 infants of 240/7-276/7 weeks of gestation while receiving supplemental oxygen during the first 3 days of life. RESULTS: Lower target infants who were small for gestational age had the lowest oxygen saturation and highest incidence of intermittent hypoxemia during the first 3 days of life. The lowest quartile of oxygen saturation (≤92%) during the first 3 days of life was associated with lower 90-day survival for both infants born appropriate and SGA. An increased incidence of intermittent hypoxemia events during the first 3 days of life was associated with lower 90-day survival only in infants born SGA. CONCLUSION: Lower achieved oxygen saturation during the first 3 days of life was associated with lower 90-day survival in extremely preterm infants. Infants born SGA had enhanced vulnerability to lower oxygen saturation targets as evidenced by lower achieved oxygen saturation and an association between increased intermittent hypoxemia events and lower survival. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00233324.
Authors: Scott A Sands; Bradley A Edwards; Vanessa J Kelly; Elizabeth M Skuza; Malcolm R Davidson; Malcolm H Wilkinson; Philip J Berger Journal: Am J Respir Crit Care Med Date: 2010-06-03 Impact factor: 21.405
Authors: Juliann M Di Fiore; Michele Walsh; Lisa Wrage; Wade Rich; Neil Finer; Waldemar A Carlo; Richard J Martin Journal: J Pediatr Date: 2012-06-26 Impact factor: 4.406
Authors: Michele C Walsh; Juliann M Di Fiore; Richard J Martin; Marie Gantz; Waldemar A Carlo; Neil Finer Journal: JAMA Pediatr Date: 2016-03 Impact factor: 16.193
Authors: Rohan Joshi; Bart L Bierling; Xi Long; Janna Weijers; Loe Feijs; Carola Van Pul; Peter Andriessen Journal: IEEE J Transl Eng Health Med Date: 2018-10-12 Impact factor: 3.316
Authors: Rohan Joshi; Zheng Peng; Xi Long; Loe Feijs; Peter Andriessen; Carola Van Pul Journal: IEEE J Transl Eng Health Med Date: 2019-11-22 Impact factor: 3.316
Authors: Vishal S Kapadia; Charitharth V Lal; Venkat Kakkilaya; Roy Heyne; Rashmin C Savani; Myra H Wyckoff Journal: J Pediatr Date: 2017-12 Impact factor: 4.406
Authors: Kai You; Pavan Parikh; Karl Khandalavala; Sarah A Wicher; Logan Manlove; Binxia Yang; Annie Roesler; Ben B Roos; Jacob J Teske; Rodney D Britt; Christina M Pabelick; Y S Prakash Journal: Am J Physiol Lung Cell Mol Physiol Date: 2019-08-14 Impact factor: 6.011